Research Article

Assessment of the Relationship between Carotid Intima-Media Thickening and Early-Stage Diabetic Kidney Disease Coupled with Helicobacter pylori Infection

Table 1

Demographic and clinical data of the study participants.

Group AGroup BGroup CGroup DChi-square or

51384249
Age (years)46.10 ± 0.5846.79 ± 0.6346.64 ± 0.5446.61 ± 0.530.2920.831
Gender (male/female)41/1030/833/938/110.1240.989
Current smoker (%)23.53 (12/51)21.05 (8/38)23.81 (10/42)22.45 (11/49)0.1090.991
CIMT (mm)0.84 ± 0.009#△▲0.76 ± 0.0130.75 ± 0.0110.75 ± 0.00918.007<0.001
BMI (kg/m2)25.57 ± 0.2025.58 ± 0.2425.90 ± 0.2225.45 ± 0.190.8180.486
eGFR (mL/min/1.73 m2)99.31 ± 1.64#◇100.12 ± 2.20△▲107.47 ± 1.70107.54 ± 1.357.146<0.001
UACR (mg/g)100.46 ± 1.92#◇98.18 ± 2.42△▲10.45 ± 0.2910.37 ± 0.241165.8<0.001
FPG (mmol/L)7.18 ± 0.067.19 ± 0.077.34 ± 0.067.34 ± 0.061.9760.119
HbA1C (%)7.46 ± 0.077.39 ± 0.077.26 ± 0.057.26 ± 0.091.9320.126
Duration of diabetes (years)10.22 ± 0.3510.03 ± 0.299.31 ± 0.239.76 ± 0.261.7450.16
Hypertension (%)33.33 (17/51)31.58 (12/38)26.19 (11/42)30.61 (15/49)0.5810.901
TGs (mmol/L)1.85 ± 0.04#◇1.85 ± 0.04△▲1.72 ± 0.041.70 ± 0.044.0110.009
TC (mmol/L)4.57 ± 0.04#◇4.55 ± 0.05△▲4.76 ± 0.054.71 ± 0.054.6120.004
LDL (mmol/L)2.57 ± 0.022.51 ± 0.022.63 ± 0.03#◇2.51 ± 0.025.1520.002
HDL (mmol/L)1.47 ± 0.031.41 ± 0.031.47 ± 0.031.38 ± 0.03△▲2.7430.045
ApOA1 (g/L)1.50 ± 0.021.47 ± 0.031.51 ± 0.031.46 ± 0.030.8850.45
APOB (g/L)1.17 ± 0.02#△▲1.01 ± 0.031.08 ± 0.031.07 ± 0.035.3880.001
IL-6 (ng/L)35.10 ± 0.59#◇31.85 ± 0.6433.45 ± 0.7431.99 ± 0.566.1260.001
CRP (ng/L)5.44 ± 0.11#◇4.41 ± 0.155.13 ± 0.11△▲4.65 ± 0.1114.65<0.001
MDA (ng/L)11.53 ± 0.6712.13 ± 0.8211.21 ± 0.7512.58 ± 0.830.6460.586

CIMT = carotid intima media thickness; BMI = body mass index; eGFR = estimated glomerular filtration rate; UACR = urine albumin/creatinine ratio; FPG = fasting plasma glucose; HbA1C = glycosylated haemoglobin; TGs = triglycerides; TC = total cholesterol; LDL = low-density lipoprotein; HDL = high-density lipoprotein; ApoA1 = apolipoprotein A1; ApoB = apolipoprotein B; IL-6 = interleukin-6; CRP = C-reactive protein; MDA = malondialdehyde. CIMT: (group A versus group B); (group A versus group C); (group A versus group D). eGFR: (group A versus group C); (group A versus group D); (group B versus group C); (group B versus group D). UACR: (group A versus group C); (group A versus group D); (group B versus group C); (group B versus group D). TGs: (group A versus group C); (group A versus group D); (group B versus group C); (group B versus group D). TC: (group A versus group C); (group A versus group D); (group B versus group C); (group B versus group D). LDL: (group C versus group B); (group C versus group D). HDL: (group D versus group A); (group D versus group C). APOB: (group A versus group B); (group A versus group C); (group A versus group D). IL-6: (group A versus group B); (group A versus group D). CRP: (group A versus group B); (group A versus group D); (group C versus group B); (group C versus group D).